Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors

Double/triple-hit lymphomas (DHL/THL) account for 5–10% of diffuse large B cell lymphoma (DLBCL) with rearrangement of MYC and BCL2 and/or BCL6 resulting in MYC overexpression. Despite the poor prognosis of DHL, R-CHOP chemotherapy remains the treatment backbone and new targeted therapy is needed. W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hematol Oncol
Main Authors: Li, Weiping, Gupta, Shiv K., Han, Weiguo, Kundson, Ryan A., Nelson, Sara, Knutson, Darlene, Greipp, Patricia T., Elsawa, Sherine F., Sotomayor, Eduardo M., Gupta, Mamta
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Rapid Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617630/
https://ncbi.nlm.nih.gov/pubmed/31288832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0761-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados